Bookbot

Nanovaccinology as Targeted Therapeutics

Auteurs

Paramètres

  • 352pages
  • 13 heures de lecture

En savoir plus sur le livre

The book explores the early-stage development of nanovaccines, representing a new generation of vaccines with significant potential for disease prevention and treatment. It delves into recent advancements in micro- and nanofabricated engineered nanomaterials, emphasizing interdisciplinary research across polymer chemistry, nanotechnology, materials science, pharmaceuticals, and medicine. The small dimensions of these nanomaterials offer distinct advantages, potentially transforming conventional therapies and diagnostics with superior effectiveness in various biomedical fields. The growing interest in this innovative material class has spurred numerous studies aimed at discovering biogenic production methods and exploring new applications. The 19 chapters cover diverse topics, highlighting the importance of staying updated on these biomedical research developments and their emerging applications in next-generation techniques. The intended audience includes biotechnologists, nanotechnologists, materials scientists, biochemists, medical biologists, drug delivery and formulation chemists, virologists, and pharmacists, all of whom stand to benefit from the insights presented in this comprehensive exploration of nanovaccinology.

Achat du livre

Nanovaccinology as Targeted Therapeutics, K Pal

Langue
Année de publication
2022
product-detail.submit-box.info.binding
(rigide)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.

Modes de paiement

Personne n'a encore évalué .Évaluer